2024-11-07 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**Company Overview:** Colgate-Palmolive Co is a multinational consumer products company that produces and sells a wide range of oral care, personal care, home care, and pet nutrition products.

**1. Performance Comparison:**

Colgate-Palmolive (CL) has significantly underperformed the S&P 500 (VOO) in terms of cumulative returns. While the S&P 500 has generated a cumulative return of 139.88%, CL has only managed a return of 26.37%. This translates to a significant underperformance of -113.51%, meaning CL's return is 113.51% lower than the S&P 500.

**Alpha and Beta Analysis:**

* **Alpha:** Consistently negative, indicating underperformance compared to the benchmark index (S&P 500) over different periods.
* **Beta:** Generally lower than 1, suggesting CL is less volatile than the market, but still exhibits volatility.

**2. Recent Price Movement:**

* **Closing Price:** $90.22
* **5-day Moving Average:** $93.03
* **20-day Moving Average:** $97.37
* **60-day Moving Average:** $101.78

The stock is currently trading below all three moving averages, indicating a potential downward trend. However, the 5-day moving average being relatively close to the closing price could suggest a potential short-term rebound.

**3. Technical Indicators:**

* **RSI:** 14.62, indicating oversold conditions, suggesting potential for a rebound.
* **PPO:** -0.57, indicating bearish sentiment, aligning with the downward trend observed in the moving averages.
* **Delta_Previous_Relative_Divergence:** -4.7, indicating a short-term downtrend in relative strength.
* **Expected Return:** 0.0%,  meaning the stock is not expected to outperform the S&P 500 in the long run. 

**4. Recent Earnings and Outlook:**

| Date         | EPS | Revenue |
|--------------|-----|--------|
| 2024-10-25  | 0.9 | $5.03B |
| 2024-07-26  | 0.89 | $5.06B |
| 2024-04-26  | 0.83 | $5.07B |
| 2023-10-27  | 0.86 | $4.92B |
| 2024-10-25  | 0.86 | $4.92B |

Earnings have been relatively stable over the past year, indicating steady performance despite the challenging economic environment.  However, the lack of significant growth might explain the recent underperformance compared to the broader market. The latest earnings report is expected to be released on October 25th, 2024, and it will be crucial to understand the company's outlook and future growth plans. 

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|-----------|---------------|
| 2024-09-30  | $5.03B    | 61.08%        |
| 2024-06-30  | $5.06B    | 60.62%        |
| 2024-03-31  | $5.07B    | 60.00%        |
| 2023-12-31  | $4.95B    | 59.60%        |
| 2023-09-30  | $4.92B    | 58.54%        |

The company has consistently maintained high profit margins, indicating its strong position in the market. However, revenue growth has been stagnant, which might be a concern for investors.

**2) Capital and Profitability:**

| Quarter      | Equity      | ROE         |
|--------------|-------------|--------------|
| 2024-09-30  | $0.43B      | 169.43%     |
| 2024-06-30  | $0.12B      | 594.31%     |
| 2024-03-31  | $0.23B      | 296.96%     |
| 2023-12-31  | $0.61B      | 117.90%     |
| 2023-09-30  | -$0.01B     | -7866.67%    |

The company's ROE has been fluctuating, indicating potential challenges in maintaining consistent profitability. The negative equity in Q3 2023 is a concerning factor and needs further investigation.

**6. News and Recent Issues:**

* **Earnings News:**  There were no recent earnings reports for Colgate-Palmolive within the last two days.
* **Recent Market Outlook:** The current market outlook for CL remains uncertain. Analysts are divided on its future performance, with some expecting a rebound based on the company's solid fundamentals and potential cost-cutting measures. Others are more cautious, pointing to the challenges in the consumer discretionary sector and the potential for a global recession.
* **Analyst Opinions:**  Analysts' opinions on CL vary. While some analysts have rated the stock as a "Buy" or "Hold," others have assigned "Sell" ratings. Recent performance, particularly the underperformance compared to the S&P 500, has contributed to this divergence in opinions.
* **Performance Highlights:** Colgate-Palmolive continues to face challenges in its core markets, including the rising cost of raw materials and the changing consumer behavior. However, the company has been focused on cost optimization and improving its operational efficiency. It remains to be seen whether these efforts will be sufficient to drive sustainable growth and improve investor confidence.

**7. Comprehensive Analysis:**

Colgate-Palmolive has been struggling to keep pace with the market, significantly underperforming the S&P 500. The company's consistent high profit margins are a positive sign, but the stagnant revenue growth is a concern. Despite this, the recent earnings have been stable, and the company is focused on cost optimization. However, the stock is currently trading below all three moving averages, indicating a potential downward trend. The technical indicators suggest oversold conditions and bearish sentiment. The upcoming earnings report will be crucial to understanding the company's future outlook and its ability to drive growth in the challenging global market.

**8. Conclusion:**

CL is a solid company with a strong brand and a dominant position in the consumer goods market.  However, recent performance and technical indicators point to a potential downward trend. Investors looking for significant growth should consider other opportunities.  For those seeking a stable, dividend-paying stock, CL might be worth further consideration. However, it's crucial to monitor the company's upcoming earnings report and analyze the latest market developments before making any investment decisions. 
